135 related articles for article (PubMed ID: 2465940)
1. High risk malignant gestational trophoblastic disease: experience with triple chemotherapy (MAC) in Third World circumstances.
du Toit JP
Gynecol Oncol; 1989 Mar; 32(3):310-3. PubMed ID: 2465940
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
[TBL] [Abstract][Full Text] [Related]
3. Poor prognosis metastatic gestational trophoblastic disease: experience with moderate dose methotrexate plus folinic acid rescue as initial therapy.
Gerulath AH; Dembo AJ; Aitken S; Quirt IC; Osborne R; Blackstein M; Rider WD
Gynecol Oncol; 1986 Nov; 25(3):294-301. PubMed ID: 3023204
[TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic disease.
Hammond CB; Olt GJ
Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
[No Abstract] [Full Text] [Related]
5. Mono and polichemotherapy in the treatment of metastatic and invasive gestational trophoblastic disease: analysis of 50 cases.
de Andrade JM; Murta EF; de Freitas MM; Pires CR; Bighetti S
Rev Paul Med; 1993; 111(6):433-8. PubMed ID: 7519787
[TBL] [Abstract][Full Text] [Related]
6. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
7. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
Mortakis AE; Braga CA
Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
[TBL] [Abstract][Full Text] [Related]
8. Liver metastases of gestational trophoblastic tumor.
Bakri YN; Subhi J; Amer M; Ezzat A; Sinner W; Tweijry A; Jabbar FA
Gynecol Oncol; 1993 Jan; 48(1):110-3. PubMed ID: 8380786
[TBL] [Abstract][Full Text] [Related]
9. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
10. Current management of low-risk metastatic gestational trophoblastic disease.
Jones WB
J Reprod Med; 1987 Sep; 32(9):653-6. PubMed ID: 2822918
[TBL] [Abstract][Full Text] [Related]
11. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
Berkowitz RS; Goldstein DP; Bernstein MR
Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic gestational trophoblastic neoplasms. A brief review of developments in the years 1968 to 1978.
Lewis JL
Am J Obstet Gynecol; 1980 Jan; 136(2):163-72. PubMed ID: 6243444
[No Abstract] [Full Text] [Related]
13. Chemotherapy for trophoblastic disease: current standards.
Kendall A; Gillmore R; Newlands E
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):33-8. PubMed ID: 11801874
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of gestational trophoblastic disease at a single institute.
Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease.
Berkowitz RS; Goldstein DP; Bernstein MR
Cancer; 1982 Nov; 50(10):2024-7. PubMed ID: 6290020
[TBL] [Abstract][Full Text] [Related]
16. The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms.
Sobrero A; Bertino JR
Adv Exp Med Biol; 1984; 176():343-54. PubMed ID: 6093467
[No Abstract] [Full Text] [Related]
17. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
[TBL] [Abstract][Full Text] [Related]
19. Modified Bagshawe's regimen in high-risk gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Gynecol Oncol; 1986 Jan; 23(1):87-93. PubMed ID: 3002917
[TBL] [Abstract][Full Text] [Related]
20. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Matsui H; Iitsuka Y; Seki K; Sekiya S
Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
